Because ITPP relieves hypoxia and converts CT26 tumors into “hot” immunogenic tumors three hours after the first ITPP injection, we next asked whether the effect of ITPP to create an immunogenically “hot” TME is sufficient to strengthen the ICB response and promote ICB tumor control. This evidence concerns the gene DDX53 and neoplasm.